Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Symposium overview: estrogens and antiestrogens in managing the patient with breast cancer.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print Cited Medium: Print ISSN: 1068-9265 (Print) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
- Publication Information:
Publication: 2005- : New York, NY : Springer
Original Publication: New York, NY : Raven Press, c1994-
- Subject Terms:
- Abstract:
The prevalence of breast cancer (a hormonally driven neoplasm) in the United States, the potential health benefits of estrogen replacement therapy for postmenopausal women, and the burgeoning research focusing on selective estrogen receptor modulators (SERMs) have resulted in additional complexity in managing breast cancer. In an attempt to clarify existing data, the Society of Surgical Oncology sponsored a symposium entitled "Estrogens and Antiestrogens in Managing the Patient with Breast Cancer" at its 52nd Annual Cancer Symposium. This conference was held in March 1999 and was chaired by Dr. S. Eva Singletary, Professor of Surgery and Chief of the Surgical Breast Section at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. The following is a review of the material presented by the symposium participants.
- Accession Number:
0 (Antineoplastic Agents, Hormonal)
0 (Aromatase Inhibitors)
0 (Estrogen Receptor Modulators)
0 (Selective Estrogen Receptor Modulators)
094ZI81Y45 (Tamoxifen)
- Publication Date:
Date Created: 20000927 Date Completed: 20010111 Latest Revision: 20190921
- Publication Date:
20221213
- Accession Number:
10.1007/BF02725335
- Accession Number:
11005554
No Comments.